October 8, 2020: The drug should be labeled with an accurate description of its properties, not “abuse deterrent,” so that patients, family members, and healthcare providers do not erroneously assume the drug is less addictive.
Read More »Tag: FDA
Study finds removing breast implants improved symptoms
AzFamily.com, October 1, 2020. The FDA is finally encouraging better information about the risks of cancer, breast implant illness, and other health problems for women considering breast implants. But we agree with patients that the agency could do so much more.
Read More »FDA Updates Breast Implant Labeling Recommendations to Help Inform Patients About Dangerous Potential Side Effects
Cure, September 29, 2020. Makers of breast implants should include a black box warning about cancer and other serious risks, along with a patient decision checklist for patients to sign, according to final guidance issued by the FDA.
Read More »NCHR joins Nonprofits in asking FDA to only allow Covid vaccine distribution after phase 3 trials completed
August 10, 2020. Experts urge that COVID-19 vaccines are made widely available only after the Food and Drug Administration (FDA) has been able to evaluate safety and efficacy data from completed Phase 3 clinical trials.
Read More »Public health experts want rigorous FDA review of Covid vaccine data
Politico, August 7, 2020. A letter to FDA Commissioner Stephen Hahn argues that FDA should allow the distribution of a future coronavirus vaccine only after evaluating safety and effectiveness data from completed Phase 3 trials.
Read More »